Skip to main content

Table 2 Relative hazards of recurrence or death in patients with pulmonary metastases secondary to colo-rectal cancer (univariate analysis in cox proportional hazards model, time since operation for lung metastasis)

From: Predicting survival after pulmonary metastasectomy for colorectal cancer: previous liver metastases matter

 

Recurrence

Death

Gender(F versus M)

2.1 (0.8 - 5.1)

0.12

1.7 (0.6 - 4.4)

0.30

Age(per 10 years)

0.84 (0.52 - 1.34)

0.46

1.05 (0.61 - 1.79)

0.86

Primary Tumor T stage

 

0.34

 

0.60

   1-2

1.0

 

1.0

 

   3

4.0 (0.5 - 30.5)

 

2.8 (0.4 - 21.7)

 

   4

2.6 (0.3 - 23.3)

 

3.0 (0.3 - 27.1)

 

Tumor 3-4 (vs. 1-2)

3.6 (0.5 - 26.8)

0.22

2.8 (0.4 - 21.6)

0.32

Primary Tumor N stage

 

0.23

 

0.42

   0

1.0

 

1.0

 

   1

2.3 (0.8 - 6.9)

 

1.7 (0.5 - 5.6)

 

   2

2.7 (0.8 - 9.3)

 

2.2 (0.6- 7.8)

 

Node 1-2 (versus 0)

2.4 (0.9 - 6.7)

0.09

1.9 (0.7 - 5.5)

0.22

Primary tumors M stage

3.2 (1.1 - 8.9)

0.03

1.4 (0.5 - 4.5)

0.53

M1 (versus M0)

    

Stage 3-4 (versus 1-2)

2.4 (0.9 - 6.7)

0.09

1.8 (0.6 - 5.1)

0.28

Liver metastasis

3.1 (1.2 - 7.8)

0.01

2.3 (0.8 - 6.2)

0.10

Time primary to lung(per year)

0.9 (0.6 - 1.2)

0.51

1.0 (0.8 - 1.4)

0.87

Time primary to first metastasis(per year)

0.71 (0.49 - 1.02)

0.06

0.9 (0.6 - 1.2)

0.45

Multiple versus single lung metastasis

1.2 (0.5 - 3.3)

0.67

1.2 (0.9 - 1.7)

0.17

Size lung metastasis >20 mm

1.8 (0.7 - 4.8)

0.21

1.2 (0.4 - 3.2)

0.76

Neo-adjuvant treatment for lung metastasis

2.8 (0.6 - 13.0)

0.20

3.4 (0.9 - 12.4)

0.06

Adjuvant treatment for lung metastasis

0.5 (0.1 - 3.9)

0.52

1.1 (0.3 - 4.9)

0.89

Lung operation other than wedge(versus wedge)

2.3 (0.9 - 5.9)

0.06

1.8 (0.7 - 5.0)

0.23